Simplex Trading
HRTX icon

Simplex Trading’s Heron Therapeutics HRTX Stock Holding History

Simplex Trading’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12K Buy
1,400
+100
+8% +$116 ﹤0.01% 8571
2025
Q4 		$1.69K Sell
1,300
-5,200
-80% -$6.42K ﹤0.01% 7885
2025
Q3 		$8K Sell
6,500
-800
-11% -$1.27K ﹤0.01% 8025
2025
Q2 		$15K Sell
7,300
-86,300
-92% -$176K ﹤0.01% 7007
2025
Q1 		$205K Buy
93,600
+78,000
+500% +$151K ﹤0.01% 4295
2024
Q4 		$23K Sell
15,600
-11,400
-42% -$18.5K ﹤0.01% 6570
2024
Q3 		$53K Buy
27,000
+11,300
+72% +$27K ﹤0.01% 5828
2024
Q2 		$54K Sell
15,700
-124,800
-89% -$383K ﹤0.01% 6005
2024
Q1 		$389K Buy
140,500
+52,200
+59% +$131K ﹤0.01% 4100
2023
Q4 		$150K Sell
88,300
-302,700
-77% -$333K ﹤0.01% 4975
2023
Q3 		$402K Buy
+391,000
New +$556K ﹤0.01% 3624
2023
Q2 		– Sell
-4,400
Closed -$6K – 9372
2023
Q1 		$6K Sell
4,400
-1,500
-25% -$3.76K ﹤0.01% 7912
2022
Q4 		$14K Buy
5,900
+600
+11% +$1.93K ﹤0.01% 7211
2022
Q3 		$22K Sell
5,300
-3,100
-37% -$12.1K ﹤0.01% 7410
2022
Q2 		$23K Sell
8,400
-51,600
-86% -$207K ﹤0.01% 7441
2022
Q1 		$343K Buy
60,000
+53,100
+770% +$389K ﹤0.01% 4354
2021
Q4 		$62K Sell
6,900
-30,300
-81% -$309K ﹤0.01% 6940
2021
Q3 		$558K Sell
37,200
-800
-2% -$9.74K ﹤0.01% 3917
2021
Q2 		$589K Buy
38,000
+37,988
+316,567% +$604K ﹤0.01% 3898
2021
Q1 		$19K Buy
+12
New +$214 ﹤0.01% 7493
2020
Q4 		– Sell
-184
Closed -$272K – 8636
2020
Q3 		$272K Sell
184
-77
-30% -$1.2K ﹤0.01% 3717
2020
Q2 		$383K Sell
261
-670
-72% -$11K ﹤0.01% 3232
2020
Q1 		$1.09M Buy
931
+862
+1,249% +$16.2K ﹤0.01% 1797
2019
Q4 		$162K Sell
69
-17
-20% -$376 ﹤0.01% 3981
2019
Q3 		$159K Buy
86
+45
+110% +$828 ﹤0.01% 3812
2019
Q2 		$76K Sell
41
-224
-85% -$4.47K ﹤0.01% 4458
2019
Q1 		$647K Buy
265
+170
+179% +$4.45K ﹤0.01% 2393
2018
Q4 		$246K Sell
95
-3
-3% -$82 ﹤0.01% 2921
2018
Q3 		$310K Sell
98
-612
-86% -$22.8K ﹤0.01% 3136
2018
Q2 		$2.76M Buy
710
+535
+306% +$17K 0.01% 919
2018
Q1 		$93K Sell
175
-310
-64% -$7.03K ﹤0.01% 1858
2017
Q4 		$87K Buy
485
+147
+43% +$2.4K ﹤0.01% 1914
2017
Q3 		$49K Buy
338
+225
+199% +$3.53K ﹤0.01% 2317
2017
Q2 		$17K Sell
113
-6
-5% -$87 ﹤0.01% 3460
2017
Q1 		$15K Sell
119
-2
-2% -$28 ﹤0.01% 3561
2016
Q4 		$10K Sell
121
-33
-21% -$518 ﹤0.01% 3734
2016
Q3 		$13K Buy
154
+110
+250% +$2.04K ﹤0.01% 3377
2016
Q2 		$3K Sell
44
-283
-87% -$5.53K ﹤0.01% 4641
2016
Q1 		$44K Buy
327
+316
+2,873% +$6.24K ﹤0.01% 2062
2015
Q4 		$2K Sell
11
-659
-98% -$17.6K ﹤0.01% 4502
2015
Q3 		$23K Buy
670
+343
+105% +$11.4K ﹤0.01% 2648
2015
Q2 		$218K Buy
327
+253
+342% +$4.76K 0.02% 757
2015
Q1 		$5K Buy
+74
New +$834 ﹤0.01% 3501

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Simplex Trading's HRTX Position: Q1 2026 in Review

Simplex Trading reduced its Heron Therapeutics (HRTX) stake by 89% in Q1 2026, selling an estimated $118K and leaving 12,774 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #7340.

Simplex Trading first reported a position in HRTX in Q1 2015 and has held it in 35 quarters since. The position peaked at $1.47M in Q2 2018. 167 funds tracked by Wall St. Rank hold HRTX as of Q1 2026.

  • Simplex Trading held 12,774 shares of Heron Therapeutics worth $10.2K as of Q1 2026.
  • Simplex Trading sold 101,830 Heron Therapeutics shares in Q1 2026, an estimated $118K.
  • Heron Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7340 holding.
  • Simplex Trading first reported a position in Heron Therapeutics in Q1 2015 and has held it in 35 quarters since.
  • Simplex Trading's Heron Therapeutics position peaked at $1.47M in Q2 2018.
  • 167 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.